Ophthalmic compositions for treating ocular hypertension

Details for Australian Patent Application No. 2007258527 (hide)

Owner Merck & Co., Inc.

Inventors Shen, Dong-Ming; Zhang, Fengqi; Doherty, James B.; Natarajan, Swaminathan R.

Agent Spruson & Ferguson

Pub. Number AU-A-2007258527

PCT Pub. Number WO2007/146136

Priority 60/812,839 12.06.06 US

Filing date 7 June 2007

Wipo publication date 21 December 2007

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/12 (2006.01) - Ketones

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

C07C 49/105 (2006.01) Ketones

C07C 49/115 (2006.01) Ketones

C07C 233/00 (2006.01) Carboxylic acid amides

C07C 233/29 (2006.01) Carboxylic acid amides

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/146136 Priority application(s): WO2007/146136

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007258529-Thiadiazole Compounds and methods of use thereof

2007258524-Layered nasal devices